FOR IMMEDIATE RELEASE | July 20, 2022
‘Heroes of Chemistry’ recognized for contributions to health, medicine and more
WASHINGTON, July 20, 2022 — The American Chemical Society (ACS) is honoring researchers and companies for developing products that have led to significant advancements in health and medicine and other consumer applications. The 2022 winners will be inducted into the Heroes of Chemistry scientific hall of fame, which ACS has sponsored annually since 1996.
“These companies are truly heroic, creating formulations to help protect against and treat COVID-19,” says ACS President Angela K. Wilson, Ph.D. “It’s also important to recognize the creative work for solutions to non-COVID-19-related problems. I’m honored to recognize 3M, Dow, Lilly, Merck, Moderna and Pfizer for making the world a better place in a variety of capacities through innovative chemistry.”
Scientific teams in industry are being honored for the following achievements:
3M: RelyX™ Unicem and Universal Dental Cements provide outstanding high performance in oral environments, significant handling advantages, simpler dental workflows and virtually no post-operative sensitivities.
Dow: Elite™ and Innate™ are precise, on-demand, molecularly tailored, enhanced polyethylenes to meet a range of packaging requirements.
Eli Lilly and Company: Verzenio® (abemaciclib) is a selective CDK4 and CDK6 inhibitor for the treatment of both advanced and metastatic, as well as high-risk early breast cancers.
Merck and Co. Inc.: Lagevrio™ (molnupiravir) is a novel antiviral for the treatment of COVID-19. It was granted emergency use authorization by the U.S. Food and Drug Administration.
Moderna: mRNA-1273 SARS-CoV-2 Vaccine (Spikevax™) is an mRNA vaccine against COVID-19, authorized by the Food and Drug Administration for individuals 18 years of age and older.
Pfizer: Paxlovid™ is a medicine granted emergency use authorization by the Food and Drug Administration for the treatment of mild to moderate COVID-19.
The Heroes of Chemistry ceremony is scheduled for Thursday, Sept. 29, in Washington, D.C.
Special thanks to the ACS Board Committee on Corporation Associates, which evaluated the applications and selected the winners.
The American Chemical Society (ACS) is a nonprofit organization chartered by the U.S. Congress. ACS’ mission is to advance the broader chemistry enterprise and its practitioners for the benefit of Earth and all its people. The Society is a global leader in promoting excellence in science education and providing access to chemistry-related information and research through its multiple research solutions, peer-reviewed journals, scientific conferences, eBooks and weekly news periodical Chemical & Engineering News. ACS journals are among the most cited, most trusted and most read within the scientific literature; however, ACS itself does not conduct chemical research. As a leader in scientific information solutions, its CAS division partners with global innovators to accelerate breakthroughs by curating, connecting and analyzing the world’s scientific knowledge. ACS’ main offices are in Washington, D.C., and Columbus, Ohio.
To automatically receive press releases from the American Chemical Society, contact email@example.com.
Note: ACS does not conduct research, but publishes and publicizes peer-reviewed scientific studies.